|
1
|
McCutcheon CA, Orme RM, Scott DA, Davies
MJ and McGlade DP: A comparison of dexmedetomidine versus
conventional therapy for sedation and hemodynamic control during
carotid endarterectomy performed under regional anesthesia. Anesth
Analg. 102:668–675. 2006. View Article : Google Scholar
|
|
2
|
Ramsay MA and Luterman DL: Dexmedetomidine
as a total intravenous anesthetic agent. Anesthesiology.
101:787–790. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Billings FT 4th, Chen SW, Kim M, et al:
alpha2-Adrenergic agonists protect against radiocontrast-induced
nephropathy in mice. Am J Physiol Renal Physiol. 295:F741–F748.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Multz AS: Prolonged dexmedetomidine
infusion as an adjunct in treating sedation-induced withdrawal.
Anesth Analg. 96:1054–1055. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paris A, Mantz J, Tonner PH, Hein L, Brede
M and Gressens P: The effects of dexmedetomidine on perinatal
excitotoxic brain injury are mediated by the alpha2A-adrenoceptor
subtype. Anesth Analg. 102:456–461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Land W, Schneeberger H, Schleibner S, et
al: The beneficial effect of human recombinant superoxide dismutase
on acute and chronic rejection events in recipients of cadaveric
renal transplants. Transplantation. 57:211–217. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Land WG: The role of postischemic
reperfusion injury and other nonantigen-dependent inflammatory
pathways in transplantation. Transplantation. 79:505–514. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O’Neill S, Ross JA, Wigmore SJ and
Harrison EM: The role of heat shock protein 90 in modulating
ischemia-reperfusion injury in the kidney. Expert Opin Investig
Drugs. 21:1535–1548. 2012.PubMed/NCBI
|
|
9
|
Malis CD and Bonventre JV: Mechanism of
calcium potentiation of oxygen free radical injury to renal
mitochondria. A model for post-ischemic and toxic mitochondrial
damage. J Biol Chem. 261:14201–14208. 1986.PubMed/NCBI
|
|
10
|
Wang QM, Stalker TJ, Gong Y, Rikitake Y,
Scalia R and Liao JK: Inhibition of Rho-kinase attenuates
endothelial-leukocyte interaction during ischemia-reperfusion
injury. Vasc Med. 17:379–385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wittner M, Sivenius J and Koistinaho J:
Alpha2-adrenoreceptor agonist, dexmedetomidine, alters acute gene
expression after global ischemia in gerbils. Neurosci Lett.
232:75–78. 1997. View Article : Google Scholar
|
|
12
|
Muszkat M, Kurnik D, Solus J, et al:
Variation in the alpha2B-adrenergic receptor gene (ADRA2B) and its
relationship to vascular response in vivo. Pharmacogenet Genomics.
15:407–414. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yağar S, Yavaş S and Karahalil B: The role
of the ADRA2A C1291G genetic polymorphism in response to
dexmedetomidine on patients undergoing coronary artery surgery. Mol
Biol Rep. 38:3383–3389. 2011.PubMed/NCBI
|
|
14
|
Hsing CH, Lin CF, So E, et al:
α2-Adrenoceptor agonist dexmedetomidine protects septic
acute kidney injury through increasing BMP-7 and inhibiting HDAC2
and HDAC5. Am J Physiol Renal Physiol. 303:F1443–F1453. 2012.
|
|
15
|
Gu J, Sun P, Zhao H, et al:
Dexmedetomidine provides renoprotection against
ischemia-reperfusion injury in mice. Crit Care. 15:R1532011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dahmani S, Rouelle D, Gressens P and Mantz
J: Effects of dexmedetomidine on hippocampal focal adhesion kinase
tyrosine phosphorylation in physiologic and ischemic conditions.
Anesthesiology. 103:969–977. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang Y, Huang X, Liu Z, et al:
Dexmedetomidine inhibits the secretion of high mobility group box 1
from lipopolysaccharide-activated macrophages in vitro. J Surg Res.
181:308–314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiu TH, Chen MJ, Yang YR, Yang JJ and
Tang FI: Action of dexmedetomidine on rat locus coeruleus neurones:
intracellular recording in vitro. Eur J Pharmacol. 285:261–268.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shirasaka T, Kannan H and Takasaki M:
Activation of a G protein-coupled inwardly rectifying K+ current
and suppression of Ih contribute to dexmedetomidine-induced
inhibition of rat hypothalamic paraventricular nucleus neurons.
Anesthesiology. 107:605–615. 2007.
|
|
20
|
Chen BS, Peng H and Wu SN:
Dexmedetomidine, an alpha2-adrenergic agonist, inhibits neuronal
delayed-rectifier potassium current and sodium current. Br J
Anaesth. 103:244–254. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Curtis FG, Vianna PT, Viero RM, et al:
Dexmedetomidine and S+-ketamine in ischemia and
reperfusion injury in the rat kidney. Acta Cir Bras. 26:202–206.
2011.PubMed/NCBI
|
|
22
|
Tanabe K, Takai S, Matsushima-Nishiwaki R,
Kato K, Dohi S and Kozawa O: Alpha2 adrenoreceptor agonist
regulates protein kinase C-induced heat shock protein 27
phosphorylation in C6 glioma cells. J Neurochem. 106:519–528. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Girault JA, Costa A, Derkinderen P,
Studler JM and Toutant M: FAK and PYK2/CAKbeta in the nervous
system: a link between neuronal activity, plasticity and survival?
Trends Neurosci. 22:257–263. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parcellier A, Tintignac LA, Zhuravleva E
and Hemmings BA: PKB and the mitochondria: AKTing on apoptosis.
Cell Signal. 20:21–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dahmani S, Paris A, Jannier V, et al:
Dexmedetomidine increases hippocampal phosphorylated extracellular
signal-regulated protein kinase 1 and 2 content by an alpha
2-adrenoceptor-independent mechanism: evidence for the involvement
of imidazoline I1 receptors. Anesthesiology. 108:457–466. 2008.
View Article : Google Scholar
|
|
26
|
Dahmani S, Rouelle D, Gressens P and Mantz
J: Characterization of the postconditioning effect of
dexmedetomidine in mouse organotypic hippocampal slice cultures
exposed to oxygen and glucose deprivation. Anesthesiology.
112:373–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu YM, Wang CC, Chen L, et al: Both
PI3K/Akt and ERK1/2 pathways participate in the protection by
dexmedetomidine against transient focal cerebral
ischemia/reperfusion injury in rats. Brain Res. 1494:1–8. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takamatsu I, Iwase A, Ozaki M, Kazama T,
Wada K and Sekiguchi M: Dexmedetomidine reduces long-term
potentiation in mouse hippocampus. Anesthesiology. 108:94–102.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du T, Li B, Liu S, et al: ERK
phosphorylation in intact, adult brain by alpha(2)-adrenergic
transactivation of EGF receptors. Neurochem Int. 55:593–600. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schaak S, Cussac D, Cayla C, et al:
Alpha(2) adrenoceptors regulate proliferation of human intestinal
epithelial cells. Gut. 47:242–250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cussac D, Schaak S, Gales C, Flordellis C,
Denis C and Paris H: alpha(2B)-Adrenergic receptors activate MAPK
and modulate proliferation of primary cultured proximal tubule
cells. Am J Physiol Renal Physiol. 282:F943–F952. 2002.PubMed/NCBI
|
|
32
|
Hanci V, Yurdakan G, Yurtlu S, Turan IÖ
and Sipahi EY: Protective effect of dexmedetomidine in a rat model
of α-naphthylthiourea-induced acute lung injury. J Surg Res.
178:424–430. 2012.PubMed/NCBI
|
|
33
|
Niittykoski M, Haapalinna A and Sirviö J:
Diminution of N-methyl-D-aspartate-induced perturbation of
neurotransmission by dexmedetomidine in the CA1 field of rat
hippocampus in vitro. Neurosci Lett. 281:95–98. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim HJ, Sohn JT, Jeong YS, et al: Direct
effect of dexmedetomidine on rat isolated aorta involves
endothelial nitric oxide synthesis and activation of the
lipoxygenase pathway. Clin Exp Pharmacol Physiol. 36:406–412. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kiliç K, Hanci V, Selek S, et al: The
effects of dexmedetomidine on mesenteric arterial
occlusion-associated gut ischemia and reperfusion-induced gut and
kidney injury in rabbits. J Surg Res. 178:223–232. 2012.PubMed/NCBI
|
|
36
|
Yan M, Dai H, Ding T, et al: Effects of
dexmedetomidine on the release of glial cell line-derived
neurotrophic factor from rat astrocyte cells. Neurochem Int.
58:549–557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hirota K, Nomura H, Kudo M, Mori N, Kudo T
and Kushikata T: Supraclinical concentrations of dexmedetomidine
evoke norepinephrine release from rat cerebrocortical slices
possible involvement of the orexin-1 receptor. Neurosci Lett.
372:142–145. 2004.
|
|
38
|
Globus MY, Busto R, Dietrich WD, Martinez
E, Valdés I and Ginsberg MD: Direct evidence for acute and massive
norepinephrine release in the hippocampus during transient
ischemia. J Cereb Blood Flow Metab. 9:892–896. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsumoto M, Zornow MH, Rabin BC and Maze
M: The alpha 2 adrenergic agonist, dexmedetomidine, selectively
attenuates ischemia-induced increases in striatal norepinephrine
concentrations. Brain Res. 627:325–329. 1993. View Article : Google Scholar
|
|
40
|
Maier C, Steinberg GK, Sun GH, Zhi GT and
Maze M: Neuroprotection by the alpha 2-adrenoreceptor agonist
dexmedetomidine in a focal model of cerebral ischemia.
Anesthesiology. 79:306–312. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Eser O, Fidan H, Sahin O, et al: The
influence of dexmedetomidine on ischemic rat hippocampus. Brain
Res. 1218:250–256. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chiu KM, Lin TY, Lu CW and Wang SJ:
Inhibitory effect of glutamate release from rat cerebrocortical
nerve terminals by α2 adrenoceptor agonist dexmedetomidine. Eur J
Pharmacol. 670:137–147. 2011.
|
|
43
|
Bickler PE and Hansen BM: Alpha
2-adrenergic agonists reduce glutamate release and glutamate
receptor-mediated calcium changes in hippocampal slices during
hypoxia. Neuropharmacology. 35:679–687. 1996. View Article : Google Scholar
|
|
44
|
Talke P and Bickler PE: Effects of
dexmedetomidine on hypoxia-evoked glutamate release and glutamate
receptor activity in hippocampal slices. Anesthesiology.
85:551–557. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Engelhard K, Werner C, Kaspar S, et al:
Effect of the alpha2-agonist dexmedetomidine on cerebral
neurotransmitter concentrations during cerebral ischemia in rats.
Anesthesiology. 96:450–457. 2002. View Article : Google Scholar
|
|
46
|
Valtonen P, Haapalinna A, Riekkinen P Sr
and Halonen T: Effect of alpha 2-adrenergic drugs dexmedetomidine
and atipamezole on extracellular amino acid levels in vivo. Eur J
Pharmacol. 285:239–246. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kose EA, Bakar B, Kasimcan O, et al:
Effects of intracisternal dexmedetomidine on cerebral neuronal
cells in rat: a preliminary study. Turk Neurosurg. 23:38–44.
2013.PubMed/NCBI
|
|
48
|
Kodera SY, Yoshida M, Dezaki K, et al:
Inhibition of insulin secretion from rat pancreatic islets by
dexmedetomidine and medetomidine, two sedatives frequently used in
clinical settings. Endocr J. 60:337–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kurt A, Ingec M, Isaoglu U, et al: An
investigation about the inhibition of acute ischemia/reperfusion
damage by dexmedetomidine in rat ovarian tissue. Gynecol
Endocrinol. 29:222–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hayashida K and Eisenach JC: Spinal
α2-adrenoceptor-mediated analgesia in neuropathic pain reflects
brain-derived nerve growth factor and changes in spinal cholinergic
neuronal function. Anesthesiology. 113:406–412. 2010.
|
|
51
|
Peng L, Li B, Du T, et al: Astrocytic
transactivation by alpha2A-adrenergic and 5-HT2B serotonergic
signaling. Neurochem Int. 57:421–431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Holers VM and Kulik L: Complement receptor
2, natural antibodies and innate immunity: Inter-relationships in B
cell selection and activation. Mol Immunol. 44:64–72. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fritz JH, Ferrero RL, Philpott DJ and
Girardin SE: Nod-like proteins in immunity, inflammation and
disease. Nat Immunol. 7:1250–1257. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sezer A, Memiş D, Usta U and Süt N: The
effect of dexmedetomidine on liver histopathology in a rat sepsis
model: an experimental pilot study. Ulus Travma Acil Cerrahi Derg.
16:108–112. 2010.PubMed/NCBI
|
|
55
|
Venn RM, Bryant A, Hall GM and Grounds RM:
Effects of dexmedetomidine on adrenocortical function, and the
cardiovascular, endocrine and inflammatory responses in
post-operative patients needing sedation in the intensive care
unit. Br J Anaesth. 86:650–656. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tasdogan M, Memis D, Sut N and Yuksel M:
Results of a pilot study on the effects of propofol and
dexmedetomidine on inflammatory responses and intraabdominal
pressure in severe sepsis. J Clin Anesth. 21:394–400. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lin Y, Zhu X, Yao WZ, Yang YL, ALT and
Chen L: Yohimbine protects against endotoxin-induced acute lung
injury by blockade of alpha 2A adrenergic receptor in rats. Chin
Med J (Engl). 124:1069–1074. 2011.PubMed/NCBI
|
|
58
|
Kishikawa H, Kobayashi K, Takemori K,
Okabe T, Ito K and Sakamoto A: The effects of dexmedetomidine on
human neutrophil apoptosis. Biomed Res. 29:189–194. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Uysal HY, Cuzdan SS, Kayiran O, et al:
Preventive effect of dexmedetomidine in ischemia-reperfusion
injury. J Craniofac Surg. 23:1287–1291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lai YC, Tsai PS and Huang CJ: Effects of
dexmedetomidine on regulating endotoxin-induced up-regulation of
inflammatory molecules in murine macrophages. J Surg Res.
154:212–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang H, Zhou F, Li C, et al: Molecular
mechanisms underlying the analgesic property of intrathecal
dexmedetomidine and its neurotoxicity evaluation: an in vivo and in
vitro experimental study. PLoS One. 8:e555562013. View Article : Google Scholar
|
|
62
|
Peng M, Wang YL, Wang CY and Chen C:
Dexmedetomidine attenuates lipopolysaccharide-induced
proinflammatory response in primary microglia. J Surg Res.
179:e219–e225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Memiş D, Hekimoğlu S, Vatan I, Yandim T,
Yüksel M and Süt N: Effects of midazolam and dexmedetomidine on
inflammatory responses and gastric intramucosal pH to sepsis, in
critically ill patients. Br J Anaesth. 98:550–552. 2007.PubMed/NCBI
|
|
64
|
Polat B, Albayrak Y, Suleyman B, et al:
Antiulcerative effect of dexmedetomidine on indomethacin-induced
gastric ulcer in rats. Pharmacol Rep. 63:518–526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Walker SM, Howard RF, Keay KA and
Fitzgerald M: Developmental age influences the effect of epidural
dexmedetomidine on inflammatory hyperalgesia in rat pups.
Anesthesiology. 102:1226–1234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Happe HK, Bylund DB and Murrin LC:
Alpha(2)-adrenoceptor-stimulated GTP gamma S binding in rat brain:
an autoradiographic study. Eur J Pharmacol. 399:17–27. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jansson CC, Pohjanoksa K, Lang J, Wurster
S, Savola JM and Scheinin M: Alpha2-adrenoceptor agonists stimulate
high-affinity GTPase activity in a receptor subtype-selective
manner. Eur J Pharmacol. 374:137–146. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Lawrence CJ, Prinzen FW and de Lange S:
The effect of dexmedetomidine on nutrient organ blood flow. Anesth
Analg. 83:1160–1165. 1996.PubMed/NCBI
|
|
69
|
Geze S, Cekic B, Imamoğlu M, et al: Use of
dexmedetomidine to prevent pulmonary injury after pneumoperitoneum
in ventilated rats. Surg Laparosc Endosc Percutan Tech. 22:447–453.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Laudenbach V, Mantz J, Lagercrantz H,
Desmonts JM, Evrard P and Gressens P: Effects of
alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain
injury: comparison of clonidine and dexmedetomidine.
Anesthesiology. 96:134–141. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Davies MF, Tsui J, Flannery JA, Li X,
DeLorey TM and Hoffman BB: Activation of alpha2 adrenergic
receptors suppresses fear conditioning: expression of c-Fos and
phosphorylated CREB in mouse amygdala. Neuropsychopharmacology.
29:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Mimuro S, Katoh T, Suzuki A, et al:
Deterioration of myocardial injury due to dexmedetomidine
administration after myocardial ischaemia. Resuscitation.
81:1714–1717. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Willigers HM, Prinzen FW, Roekaerts PM, de
Lange S and Durieux ME: Dexmedetomidine decreases perioperative
myocardial lactate release in dogs. Anesth Analg. 96:657–664. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Okada H, Kurita T, Mochizuki T, Morita K
and Sato S: The cardioprotective effect of dexmedetomidine on
global ischaemia in isolated rat hearts. Resuscitation. 74:538–545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Roekaerts PM, Prinzen FW and De Lange S:
Beneficial effects of dexmedetomidine on ischaemic myocardium of
anaesthetized dogs. Br J Anaesth. 77:427–429. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Kocoglu H, Ozturk H, Ozturk H, Yilmaz F
and Gulcu N: Effect of dexmedetomidine on ischemia-reperfusion
injury in rat kidney: a histopathologic study. Ren Fail. 31:70–74.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Marangoni MA, Hausch A, Vianna PT, Braz
JR, Viero RM and Castiglia YM: Renal function and histology after
acute hemorrhage in rats under dexmedetomidine action. Acta Cir
Bras. 22:291–298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Villela NR, do Nascimento Júnior P, de
Carvalho LR and Teixeira A: Effects of dexmedetomidine on renal
system and on vasopressin plasma levels. Experimental study in
dogs. Rev Bras Anestesiol. 55:429–440. 2005.PubMed/NCBI
|
|
79
|
Frumento RJ, Logginidou HG, Wahlander S,
Wagener G, Playford HR and Sladen RN: Dexmedetomidine infusion is
associated with enhanced renal function after thoracic surgery. J
Clin Anesth. 18:422–426. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Bayram A, Esmaoglu A, Akin A, et al: The
effects of intraoperative infusion of dexmedetomidine on early
renal function after percutaneous nephrolithotomy. Acta
Anaesthesiol Scand. 55:539–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yang CL, Chen CH, Tsai PS, Wang TY and
Huang CJ: Protective effects of dexmedetomidine-ketamine
combination against ventilator-induced lung injury in endotoxemia
rats. J Surg Res. 167:e273–e281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hanci V, Erol B, Bektaş S, et al: Effect
of dexmedetomidine on testicular torsion/detorsion damage in rats.
Urol Int. 84:105–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Gu J, Chen J, Xia P, Tao G, Zhao H and Ma
D: Dexmedetomidine attenuates remote lung injury induced by renal
ischemia-reperfusion in mice. Acta Anaesthesiol Scand.
55:1272–1278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Sanders RD, Xu J, Shu Y, et al:
Dexmedetomidine attenuates isoflurane-induced neurocognitive
impairment in neonatal rats. Anesthesiology. 110:1077–1085. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Bekker A, Haile M, Kline R, et al: The
effect of intraoperative infusion of dexmedetomidine on the quality
of recovery after major spinal surgery. J Neurosurg Anesthesiol.
25:16–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kuhmonen J, Pokorný J, Miettinen R, et al:
Neuroprotective effects of dexmedetomidine in the gerbil
hippocampus after transient global ischemia. Anesthesiology.
87:371–377. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Goyagi T, Nishikawa T, Tobe Y and Masaki
Y: The combined neuroprotective effects of lidocaine and
dexmedetomidine after transient forebrain ischemia in rats. Acta
Anaesthesiol Scand. 53:1176–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sato K, Kimura T, Nishikawa T, Tobe Y and
Masaki Y: Neuroprotective effects of a combination of
dexmedetomidine and hypothermia after incomplete cerebral ischemia
in rats. Acta Anaesthesiol Scand. 54:377–382. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ma D, Hossain M, Rajakumaraswamy N, et al:
Dexmedetomidine produces its neuroprotective effect via the alpha
2A-adrenoceptor subtype. Eur J Pharmacol. 502:87–97. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Benggon M, Chen H, Applegate R, Martin R
and Zhang JH: Effect of dexmedetomidine on brain edema and
neurological outcomes in surgical brain injury in rats. Anesth
Analg. 115:154–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Gul S, Hanci V, Bahadir B, et al: The
effectiveness of dexmedetomidine in experimental spinal cord injury
compared to methylprednisolone in rats. J Clin Neurosci.
17:490–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Can M, Gul S, Bektas S, Hanci V and
Acikgoz S: Effects of dexmedetomidine or methylprednisolone on
inflammatory responses in spinal cord injury. Acta Anaesthesiol
Scand. 53:1068–1072. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Aslan A, Cemek M, Eser O, et al: Does
dexmedetomidine reduce secondary damage after spinal cord injury?
An experimental study. Eur Spine J. 18:336–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Bell MT, Puskas F, Smith PD, et al:
Attenuation of spinal cord ischemia-reperfusion injury by specific
α-2a receptor activation with dexmedetomidine. J Vasc Surg.
56:1398–1402. 2012.
|
